Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18665158rdf:typepubmed:Citationlld:pubmed
pubmed-article:18665158lifeskim:mentionsumls-concept:C0025011lld:lifeskim
pubmed-article:18665158lifeskim:mentionsumls-concept:C0214743lld:lifeskim
pubmed-article:18665158lifeskim:mentionsumls-concept:C0017638lld:lifeskim
pubmed-article:18665158lifeskim:mentionsumls-concept:C0080194lld:lifeskim
pubmed-article:18665158lifeskim:mentionsumls-concept:C0184511lld:lifeskim
pubmed-article:18665158lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:18665158lifeskim:mentionsumls-concept:C0037791lld:lifeskim
pubmed-article:18665158lifeskim:mentionsumls-concept:C0750502lld:lifeskim
pubmed-article:18665158lifeskim:mentionsumls-concept:C1518581lld:lifeskim
pubmed-article:18665158pubmed:issue9lld:pubmed
pubmed-article:18665158pubmed:dateCreated2008-8-26lld:pubmed
pubmed-article:18665158pubmed:abstractTextThe majority of glioblastoma multiforme (GBM) tumors (80%) overexpress interleukin-13 receptor alpha2 (IL-13Ralpha2), but there is no expression of IL-13Ralpha2 in normal brain. Vaccine strains of measles virus have significant antitumor activity against gliomas. We tested the hypothesis that measles virus entry could be retargeted via the IL-13Ralpha2. MV-GFP-H(AA)-IL-13 was generated from the Edmonston-NSe vaccine strain, by displaying human IL-13 at the C-terminus of the H protein, and introducing CD46 and signaling lymphocyte activation molecule (SLAM)-ablating mutations in H. The IL-13 retargeted virus showed significant cytopathic effect (CPE) against IL-13Ralpha2 overexpressing glioma lines, and lack of CPE/viral replication in normal human astrocytes and normal human fibroblasts not expressing IL-13Ralpha2. In vivo treatment of orthotopically implanted GBM12 xenografts demonstrated significant prolongation of survival in mice treated with the retargeted strain (P < 0.0001), and comparable activity between the IL-13R retargeted strain and MV-GFP (P = 0.6377). In contrast to MV-GFP-treated mice, administration of the retargeted strain in the central nervous system of measles replication-permissive Ifnar(ko) CD46 Ge mice resulted in lack of neurotoxicity. Strains of measles virus retargeted against the glioma-specific IL-13Ralpha2 receptor have comparable therapeutic efficacy, and improved specificity as compared with the unmodified measles virus strain MV-GFP in vitro and in vivo.lld:pubmed
pubmed-article:18665158pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:languageenglld:pubmed
pubmed-article:18665158pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:citationSubsetIMlld:pubmed
pubmed-article:18665158pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18665158pubmed:statusMEDLINElld:pubmed
pubmed-article:18665158pubmed:monthSeplld:pubmed
pubmed-article:18665158pubmed:issn1525-0024lld:pubmed
pubmed-article:18665158pubmed:authorpubmed-author:SchroederMark...lld:pubmed
pubmed-article:18665158pubmed:authorpubmed-author:PuriRaj KRKlld:pubmed
pubmed-article:18665158pubmed:authorpubmed-author:IankovIankoIlld:pubmed
pubmed-article:18665158pubmed:authorpubmed-author:RussellStephe...lld:pubmed
pubmed-article:18665158pubmed:authorpubmed-author:GalanisEvanth...lld:pubmed
pubmed-article:18665158pubmed:authorpubmed-author:GianniniCater...lld:pubmed
pubmed-article:18665158pubmed:authorpubmed-author:AllenCoryClld:pubmed
pubmed-article:18665158pubmed:authorpubmed-author:SarkariaJannJlld:pubmed
pubmed-article:18665158pubmed:authorpubmed-author:ParaskevakouG...lld:pubmed
pubmed-article:18665158pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18665158pubmed:volume16lld:pubmed
pubmed-article:18665158pubmed:ownerNLMlld:pubmed
pubmed-article:18665158pubmed:authorsCompleteYlld:pubmed
pubmed-article:18665158pubmed:pagination1556-64lld:pubmed
pubmed-article:18665158pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:18665158pubmed:meshHeadingpubmed-meshheading:18665158...lld:pubmed
pubmed-article:18665158pubmed:meshHeadingpubmed-meshheading:18665158...lld:pubmed
pubmed-article:18665158pubmed:meshHeadingpubmed-meshheading:18665158...lld:pubmed
pubmed-article:18665158pubmed:meshHeadingpubmed-meshheading:18665158...lld:pubmed
pubmed-article:18665158pubmed:meshHeadingpubmed-meshheading:18665158...lld:pubmed
pubmed-article:18665158pubmed:meshHeadingpubmed-meshheading:18665158...lld:pubmed
pubmed-article:18665158pubmed:meshHeadingpubmed-meshheading:18665158...lld:pubmed
pubmed-article:18665158pubmed:meshHeadingpubmed-meshheading:18665158...lld:pubmed
pubmed-article:18665158pubmed:meshHeadingpubmed-meshheading:18665158...lld:pubmed
pubmed-article:18665158pubmed:meshHeadingpubmed-meshheading:18665158...lld:pubmed
pubmed-article:18665158pubmed:meshHeadingpubmed-meshheading:18665158...lld:pubmed
pubmed-article:18665158pubmed:meshHeadingpubmed-meshheading:18665158...lld:pubmed
pubmed-article:18665158pubmed:meshHeadingpubmed-meshheading:18665158...lld:pubmed
pubmed-article:18665158pubmed:meshHeadingpubmed-meshheading:18665158...lld:pubmed
pubmed-article:18665158pubmed:meshHeadingpubmed-meshheading:18665158...lld:pubmed
pubmed-article:18665158pubmed:meshHeadingpubmed-meshheading:18665158...lld:pubmed
More...